COMPASS Pathways PLC (CMPS)
Stock Price:
$38.39 USD
4.19 (12.25%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed
After-hours: $38.00 -0.39 (-1.02%) Oct 23, 7:53 PM
Key Info
| Market Cap |
1.38B |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-38.15M |
| Shares Out |
33.45M |
| EPS (ttm) |
-1.14 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 23, 2020 |
| Last Price |
$38.39 |
| Previous Close |
$34.20 |
| Change ($) |
4.19 |
| Change (%) |
12.25% |
| Day's Open |
34.39 |
| Day's Range |
33.35 - 40.00 |
| Day's Volume |
2,157,152 |
| 52-Week Range |
22.51 - 47.29 |
More Stats
| Market Cap |
1.38B |
| Enterprise Value |
1.38B |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
33.45M |
| Float |
n/a |
| EPS (basic) |
-0.30 |
| EPS (diluted) |
-1.14 |
| FCF / Share |
-0.27 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
373,699 |
| Short Ratio |
0.32 |
| Short % of Float |
n/a |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
n/a |
| Revenue |
n/a |
| Operating Income |
-21.18M |
| Net Income |
-38.15M |
| Free Cash Flow |
-17.98M |
| Net Cash |
3.90M |
| Net Cash / Share |
0.11 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
-626.50% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (5)
| Buy |
5 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$65.00*
(69.31% upside)
Low
50.0
Current: $38.39
High
80.0
Target: 65.00
*Average 12-month price target from 4 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 |
|---|
| Revenue | - | - |
| Operating Income | -21.18 | -12.50 |
| Net Income | -19.61 | -13.22 |
| Shares Outstanding | 65.81 | 33.13 |
| Earnings Per Share | -0.30 | -0.40 |
| Operating Cash Flow | -17.81 | -9.80 |
| Capital Expenditures | -0.17 | -0.13 |
| Free Cash Flow | -17.98 | -9.93 |
| Cash & Equivalents | 24.98 | 22.91 |
| Total Debt | 21.09 | - |
| Net Cash / Debt | 3.90 | 22.91 |
| Assets | 32.39 | 26.39 |
| Liabilities | 23.87 | 1.85 |
| Book Value | -30.39 | -14.37 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
COMPASS Pathways PLC |
| Country |
United Kingdom |
| Employees |
48 |
| CEO |
George Jay Goldsmith |
Stock Information
| Ticker Symbol |
CMPS |
| Stock Exchange |
NASDAQ |
| Sector |
Health Technology |
| Industry |
Biotechnology |
| Unique Identifier |
NASDAQ: CMPS |
| IPO Date |
September 18, 2020 |
Description
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.